Dr Ing Hc Stock Net Income
| DRPRY Stock | 4.84 0.05 1.04% |
As of the 11th of February 2026, Dr Ing owns the Standard Deviation of 1.86, market risk adjusted performance of (0.19), and Information Ratio of (0.12). Dr Ing hc technical analysis allows you to utilize past data patterns in order to determine a pattern that computes the direction of the firm's future prices.
Dr Ing's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Dr Ing's valuation are provided below:Dr Ing hc does not right now have any fundamental measures for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. DRPRY |
Dr Ing 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Dr Ing's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Dr Ing.
| 11/13/2025 |
| 02/11/2026 |
If you would invest 0.00 in Dr Ing on November 13, 2025 and sell it all today you would earn a total of 0.00 from holding Dr Ing hc or generate 0.0% return on investment in Dr Ing over 90 days. Dr Ing is related to or competes with Dr Ing, Mahindra Mahindra, Volkswagen, Volkswagen, Volkswagen, Volkswagen, and Honda. More
Dr Ing Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Dr Ing's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Dr Ing hc upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.12) | |||
| Maximum Drawdown | 9.33 | |||
| Value At Risk | (2.98) | |||
| Potential Upside | 3.22 |
Dr Ing Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Dr Ing's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Dr Ing's standard deviation. In reality, there are many statistical measures that can use Dr Ing historical prices to predict the future Dr Ing's volatility.| Risk Adjusted Performance | (0.05) | |||
| Jensen Alpha | (0.19) | |||
| Total Risk Alpha | (0.33) | |||
| Treynor Ratio | (0.20) |
Dr Ing February 11, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.05) | |||
| Market Risk Adjusted Performance | (0.19) | |||
| Mean Deviation | 1.37 | |||
| Coefficient Of Variation | (1,493) | |||
| Standard Deviation | 1.86 | |||
| Variance | 3.47 | |||
| Information Ratio | (0.12) | |||
| Jensen Alpha | (0.19) | |||
| Total Risk Alpha | (0.33) | |||
| Treynor Ratio | (0.20) | |||
| Maximum Drawdown | 9.33 | |||
| Value At Risk | (2.98) | |||
| Potential Upside | 3.22 | |||
| Skewness | (0.05) | |||
| Kurtosis | 0.8325 |
Dr Ing hc Backtested Returns
Dr Ing hc retains Efficiency (Sharpe Ratio) of -0.0982, which denotes the company had a -0.0982 % return per unit of price deviation over the last 3 months. Dr Ing exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Dr Ing's Market Risk Adjusted Performance of (0.19), standard deviation of 1.86, and Information Ratio of (0.12) to check the risk estimate we provide. The firm owns a Beta (Systematic Risk) of 0.66, which means possible diversification benefits within a given portfolio. As returns on the market increase, Dr Ing's returns are expected to increase less than the market. However, during the bear market, the loss of holding Dr Ing is expected to be smaller as well. At this point, Dr Ing hc has a negative expected return of -0.19%. Please make sure to confirm Dr Ing's jensen alpha, as well as the relationship between the kurtosis and price action indicator , to decide if Dr Ing hc performance from the past will be repeated in the future.
Auto-correlation | -0.61 |
Very good reverse predictability
Dr Ing hc has very good reverse predictability. Overlapping area represents the amount of predictability between Dr Ing time series from 13th of November 2025 to 28th of December 2025 and 28th of December 2025 to 11th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Dr Ing hc price movement. The serial correlation of -0.61 indicates that roughly 61.0% of current Dr Ing price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.61 | |
| Spearman Rank Test | -0.47 | |
| Residual Average | 0.0 | |
| Price Variance | 0.07 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Dr Ing hc reported net income of 4.03 B. This is much higher than that of the sector and significantly higher than that of the Net Income industry. The net income for all United States stocks is notably lower than that of the firm.
DRPRY Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Dr Ing's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Dr Ing could also be used in its relative valuation, which is a method of valuing Dr Ing by comparing valuation metrics of similar companies.Dr Ing is currently under evaluation in net income category among its peers.
DRPRY Fundamentals
| Profit Margin | 0.14 % | |||
| Operating Margin | 0.20 % | |||
| Revenue | 36.76 B | |||
| Gross Profit | 8.99 B | |||
| EBITDA | 9.38 B | |||
| Net Income | 4.03 B | |||
| Book Value Per Share | 25.19 X | |||
| Cash Flow From Operations | 6.42 B | |||
| Number Of Employees | 36.52 K |
About Dr Ing Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Dr Ing hc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Dr Ing using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Dr Ing hc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for DRPRY Pink Sheet Analysis
When running Dr Ing's price analysis, check to measure Dr Ing's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dr Ing is operating at the current time. Most of Dr Ing's value examination focuses on studying past and present price action to predict the probability of Dr Ing's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dr Ing's price. Additionally, you may evaluate how the addition of Dr Ing to your portfolios can decrease your overall portfolio volatility.